Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: A Delphi technique-based consensus

Simple item page
dc.contributor.authorArab, Juan
dc.contributor.authorClaro, Juan
dc.contributor.authorArancibia, Juan
dc.contributor.authorContreras, Jorge
dc.contributor.authorGomez, Fernando
dc.contributor.authorMuñoz, Cristian
dc.contributor.authorNazal, Leyla
dc.contributor.authorRoessler, Eric
dc.contributor.authorWolff, Rodrigo
dc.contributor.authorArrese, Marco
dc.contributor.authorBenitez, Carlos
dc.date.accessioned2018-01-05T13:05:06Z
dc.date.available2018-01-05T13:05:06Z
dc.date.issued2016
dc.description.abstractAIM To propose several alternatives treatment of type 1 hepatorenal syndrome (HRS-1) what is the most severe expression of circulatory dysfunction on patients with portal hypertension. METHODS A group of eleven gastroenterologists and nephrologists performed a structured analysis of available literature. Each expert was designated to review and answer a question. They generated draft statements for evaluation by all the experts. Additional input was obtained from medical community. In order to reach consensus, a modified three-round Delphi technique method was used. According to United States Preventive Services Task Force criteria, the quality of the evidence and level of recommendation supporting each statement was graded. RESULTS Nine questions were formulated. The available evidence was evaluated considering its quality, number of patients included in the studies and the consistency of its results. The generated questions were answered by the expert panel with a high level of agreement. Thus, a therapeutic algorithm was generated. The role of terlipressin and norepinephrine was confirmed as the pharmacologic treatment of choice. On the other hand the use of the combination of octreotide, midodrine and albumin without vasoconstrictors was discouraged. The role of several other options was also evaluated and the available evidence was explored and discussed. Liver transplantation is considered the definitive treatment for HRS-1. The present consensus is an important effort that intends to organize the available strategies based on the available evidence in the literature, the quality of the evidence and the benefits, adverse effects and availability of the therapeutic tools described. CONCLUSION Based on the available evidence the expert panel was able to discriminate the most appropriate therapeutic alternatives for the treatment of HRS-1.
dc.format.extent13
dc.identifier.citationWorld J Hepatol. 2016 Sep 8; 8(25): 1075–1086
dc.identifier.urihttp://hdl.handle.net/11447/1863
dc.identifier.urihttp://dx.doi.org/10.4254/wjh.v8.i25.1075
dc.language.isoen_US
dc.publisherBaishideng Publishing Group
dc.subjectHepatorenal syndrome
dc.subjectDelphi
dc.subjectConsensus
dc.subjectEvidence-based medicine
dc.subjectTreatment
dc.titleTherapeutic alternatives for the treatment of type 1 hepatorenal syndrome: A Delphi technique-based consensus
dc.typeArtículo

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome A Delphi technique-based consensus__completo.pdf
Size:
999.7 KB
Format:
Adobe Portable Document Format
Description:
Texto completo
Download

Collections

Artículos Medicina y Ciencias de la Salud

Implementado por OpenGeek Services